Receptos Jumps; May Get Close to $350/Shr in Buyout: Wedbush
2015-06-16 18:39:25.192 GMT
By Cristin Flanagan and Joshua Fineman
(Bloomberg) -- Receptos could get $348/shr or $10.9b in
acquisition after reports of bidding war, Wedbush analyst Liana
Moussatos writes in note.
* Acquisition value raised to $348 vs $211 “on increased
industry interest”
* Estimates ozanimod peak rev. >$15b in RMS, IBD
* NOTE: June 9, Receptos Said to Rebuff $200 Bid:
Proactiveinvestors; April 1, Receptos Said to Get M&A
Interest Amid Partnership Talks
* RCPT climbs as much as 7.5%
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
To contact the reporters on this story:
Cristin Flanagan in New York at +1-212-617-8919 or
cflanagan1@bloomberg.net;
Joshua Fineman in New York at +1-212-617-8953 or
jfineman@bloomberg.net
To contact the editors responsible for this story:
Arie Shapira at +1-212-617-1488 or
ashapira3@bloomberg.net
Cristin Flanagan
2015-06-16 18:39:25.192 GMT
By Cristin Flanagan and Joshua Fineman
(Bloomberg) -- Receptos could get $348/shr or $10.9b in
acquisition after reports of bidding war, Wedbush analyst Liana
Moussatos writes in note.
* Acquisition value raised to $348 vs $211 “on increased
industry interest”
* Estimates ozanimod peak rev. >$15b in RMS, IBD
* NOTE: June 9, Receptos Said to Rebuff $200 Bid:
Proactiveinvestors; April 1, Receptos Said to Get M&A
Interest Amid Partnership Talks
* RCPT climbs as much as 7.5%
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
To contact the reporters on this story:
Cristin Flanagan in New York at +1-212-617-8919 or
cflanagan1@bloomberg.net;
Joshua Fineman in New York at +1-212-617-8953 or
jfineman@bloomberg.net
To contact the editors responsible for this story:
Arie Shapira at +1-212-617-1488 or
ashapira3@bloomberg.net
Cristin Flanagan